Pulse Biosciences (PLSE) vs Stevanato Group S.p.A. (STVN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Pulse Biosciences (PLSE) has outperformed Stevanato Group S.p.A. (STVN) over the past year, gaining 150.7% versus a loss of 21.8%. Over five years, PLSE leads with a +130.9% price change compared with -21.0% for STVN. Stevanato Group S.p.A. is the larger company by market cap ($5.25 billion vs $3.56 billion), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PLSE | STVN |
|---|---|---|
| Share price | $49.98 | $19.21 |
| Market cap | $3.56B | $5.25B |
| 1-day change | +1.81% | -1.18% |
| YTD return | +264.02% | -4.52% |
| 1-year return | +150.65% | -21.85% |
| 5-year return | +130.85% | -21.01% |
| P/E ratio (TTM) | — | 33.70 |
| Forward P/E | — | 23.02 |
| EPS (TTM) | $-1.18 | $0.57 |
| Dividend yield | 0.00% | 0.32% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $350.00K | — |
| Net income (latest FY) | $-72.78M | — |
| Gross margin | -54.00% | — |
| Operating margin | -21982.57% | — |
| Net margin | -20794.57% | — |
| 52-week high | $58.90 | $27.99 |
| 52-week low | $12.56 | $12.89 |
| Distance from 52-week high | -15.14% | -31.37% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +13.05% | +28.47% |
| Average volume | 502.81K | 370.27K |
| Shares outstanding | 71.32M | 49.83M |
| Employees | 116 | 6,010 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PLSE has outperformed STVN by 172.5 percentage points over the past year.
About Pulse Biosciences
PLSE stock →Pulse Biosciences, Inc. operates as a novel bioelectric medicine company.
Health Care · Medical/Dental Instruments · 116 employees
About Stevanato Group S.p.A.
STVN stock →Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.
Health Care · Medical/Dental Instruments · 6,010 employees
PLSE vs STVN FAQ
Which is bigger, Pulse Biosciences or Stevanato Group S.p.A.?
Stevanato Group S.p.A. (STVN) is larger, with a market capitalization of $5.25B compared with $3.56B for Pulse Biosciences (PLSE).
Which stock has performed better over the past year, PLSE or STVN?
PLSE returned +150.65% over the past 12 months, compared with -21.85% for STVN (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Pulse Biosciences or Stevanato Group S.p.A.?
Stevanato Group S.p.A. pays a dividend yielding 0.32%, while Pulse Biosciences does not currently pay a regular dividend.
Are Pulse Biosciences and Stevanato Group S.p.A. in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.